Developing new treatments for COVID-19
DEVELOPMENT OF THERAPEUTIC PRODUCTS FOR COVID-19
This study is working on a new treatment for COVID-19 and similar illnesses that could help patients feel better, and it involves making sure the medicine is safe and effective before it’s available for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10451450 on NIH RePORTER |
What this research studies
This research focuses on creating and advancing a promising therapeutic product aimed at treating COVID-19 and other emerging infectious diseases. The project involves several stages, including optimizing the chemistry of the therapeutic agent, ensuring it can be manufactured under good manufacturing practices (GMP), and conducting preclinical and clinical assessments to evaluate its safety and effectiveness. Patients may benefit from new treatment options that could improve outcomes for COVID-19 and similar diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by COVID-19 or those at high risk for severe disease due to underlying health conditions.
Not a fit: Patients who are not affected by COVID-19 or similar infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective new treatments for COVID-19, potentially improving recovery rates and reducing severity of the disease.
How similar studies have performed: Other research efforts targeting COVID-19 therapeutics have shown promise, indicating that this approach is building on existing knowledge and strategies.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Glenn, Jeffrey — Stanford University
- Study coordinator: Glenn, Jeffrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.